| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/28/2009 | CA2705599A1 New compounds |
| 05/28/2009 | CA2705596A1 New compounds |
| 05/28/2009 | CA2705405A1 New compounds |
| 05/28/2009 | CA2705296A1 Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators |
| 05/28/2009 | CA2705011A1 Biaryl substituted diazabicycloalkane derivatives |
| 05/28/2009 | CA2704883A1 New compounds |
| 05/27/2009 | EP2062914A2 Somatostatin-dopamine chimeric analogs |
| 05/27/2009 | EP2062898A2 Spirocyclic cyclohexane derivatives |
| 05/27/2009 | EP2062895A1 Substituted azepino[4,3-b]indoles, pharmacological composition and a method for the production and use thereof |
| 05/27/2009 | EP2062889A1 Compounds |
| 05/27/2009 | EP2062884A1 Novel phenylacetic acid derivative |
| 05/27/2009 | EP2062879A1 Heterocyclic inhibitors of p38 |
| 05/27/2009 | EP2062878A1 Hydrazine amide derivative |
| 05/27/2009 | EP2062875A1 New polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide |
| 05/27/2009 | EP2062595A1 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 05/27/2009 | EP2062586A2 Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors |
| 05/27/2009 | EP2062577A1 Oleanolic acid derivatives as NO production inhibitors |
| 05/27/2009 | EP2061796A2 Azetidine and azetidinone derivatives useful in treating pain and disorders of lipid metabolism |
| 05/27/2009 | EP2061794A2 2-phenoxy pyrimidinone analogues |
| 05/27/2009 | EP2061780A1 Diaryl piperidine compounds as calcium channel blockers |
| 05/27/2009 | EP2061777A1 Benzoý1,2,3¨thiadiazine derivatives |
| 05/27/2009 | EP2061775A2 Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators |
| 05/27/2009 | EP2061774A2 Arylpiperazine derivatives and uses thereof |
| 05/27/2009 | EP2061772A2 Multi-functional small molecules as anti-proliferative agents |
| 05/27/2009 | EP2061769A1 Substituted benzimidazolone derivatives, medicaments comprising them and their use |
| 05/27/2009 | EP2061764A1 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr) |
| 05/27/2009 | EP2061743A1 Plants extracts for use in brain modulation |
| 05/27/2009 | EP2061485A1 Method of treating peripheral nerve disorders |
| 05/27/2009 | EP2061476A2 Compositions containing cdp-choline, and methods of use thereof |
| 05/27/2009 | EP2061471A1 Method of inhibition of respiratory depression using positive allosteric ampa receptor modulators |
| 05/27/2009 | EP2061465A2 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 05/27/2009 | EP2061462A2 Treating pain, diabetes and lipid metabolism disorders |
| 05/27/2009 | EP2061461A2 3-azabicyclo[4.1.0]heptane derivatives for the treatment of depression |
| 05/27/2009 | EP2061458A1 Topiramate compositions and methods for their use |
| 05/27/2009 | EP2061442A2 Treatment, prevention, and reversal of alcohol-induced brain disease |
| 05/27/2009 | EP2061314A2 Compounds for improving learning and memory |
| 05/27/2009 | EP1833826B1 Tricyclic delta-opioid modulators |
| 05/27/2009 | EP1622912B1 2-alkynyl-and 2-alkenyl-pyrazolo- [4,3-e ] -1,2,4-triazolo- [1,5-c] -pyrimidine adenosine a2a receptor antagonists |
| 05/27/2009 | EP1615925B1 Imidazopyridine derivatives as melanocortin receptor agonists |
| 05/27/2009 | EP1596852B1 Drugs containing substituted 2-aryl-aminoacetic acid compounds |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1487797B1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors |
| 05/27/2009 | EP1366075B1 New interferon beta-like molecules |
| 05/27/2009 | EP1351672B1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 05/27/2009 | EP1292678B1 G-protein coupled receptors |
| 05/27/2009 | EP1235915B1 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 05/27/2009 | EP1171424B1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 05/27/2009 | EP0934287B1 Heterocyclic esters and amides |
| 05/27/2009 | CN101443327A Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof |
| 05/27/2009 | CN101443314A Aminoquinolones as GSK-3 inhibitors |
| 05/27/2009 | CN101443312A 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
| 05/27/2009 | CN101443014A Chemical compounds |
| 05/27/2009 | CN101443010A Brain function-improving agent, and functional food containing the improving agent |
| 05/27/2009 | CN101443001A Method of treatment or prophylaxis inflammatory pain |
| 05/27/2009 | CN101442993A Adhesive preparation |
| 05/27/2009 | CN101440124A Methods for preventing mitochondrial permeability transition |
| 05/27/2009 | CN101440079A Process for the preparation of racemic citalopram and/or S- or R-citalopram |
| 05/27/2009 | CN101440061A Arylpyridone derivatives with acetylcholine esterase inhibition activity |
| 05/27/2009 | CN101439171A Chinese medicine prescription for treating epilepsy |
| 05/27/2009 | CN101439167A Chinese herbal medicine composition for treating migraine |
| 05/27/2009 | CN101439157A Chinese medicine composing prescription for treating fantod, irritability and insomnia caused by heart fire and dry heat as wind |
| 05/27/2009 | CN101439156A Chinese medicine composing prescription for treating insomnia induced by gallbladder-heat and phlegm-heat |
| 05/27/2009 | CN101439154A Gastrodia tuber medicament for treating insomnia |
| 05/27/2009 | CN101439136A Plaster for treating bone disease and soft tissue injury |
| 05/27/2009 | CN101439135A Chinese medicine granule containing extract of grassleaved sweetflag rhizome and preparation method thereof |
| 05/27/2009 | CN101439132A Chinese medicine composing prescription for treating insomnia induced by excessive heart fire and kidney-yin deficiency |
| 05/27/2009 | CN101439131A Chinese medicinal composition for treating phonosensitive nerve deafness and use thereof |
| 05/27/2009 | CN101439121A Pure medicinal formulation for stopping smoking |
| 05/27/2009 | CN101439120A Chinese medicine composing prescription for treating heart-spleen deficiency induced insomnia |
| 05/27/2009 | CN101439111A Medicinal liquor containing Chinese herbal medicine for treating epilepsy |
| 05/27/2009 | CN101439105A Chinese medicine granule containing spina date seed extract and preparation method thereof |
| 05/27/2009 | CN101439073A Application of Chinese medicinal composition in preparing medicament for preventing and treating dysmnesia and improving memory |
| 05/27/2009 | CN101439063A Chinese medicine granular formulation containing Chinese angelica extract and preparation method thereof |
| 05/27/2009 | CN101439059A Ginkgo leaf extract drop and preparation method thereof |
| 05/27/2009 | CN101439024A Abuse-resistant opioid dosage form |
| 05/27/2009 | CN101438746A Health tea for giving up smoking |
| 05/27/2009 | CN101438658A Fragrance-smelling section for improving sleep |
| 05/27/2009 | CN100491528C Nucleic acid sequence related with risperidone clinical curative effect |
| 05/27/2009 | CN100491389C Sialic combined immunoglobulin like agglutinin inhibitors |
| 05/27/2009 | CN100491378C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 05/27/2009 | CN100491374C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors |
| 05/27/2009 | CN100491371C Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
| 05/27/2009 | CN100491368C Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/27/2009 | CN100491366C Use of wogonin as medicament for treatment of anxiety |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 05/27/2009 | CN100491342C Crystalline beta2 adrenergic receptor agonist |
| 05/27/2009 | CN100490915C Otolaryngological delivery device |
| 05/27/2009 | CN100490846C Medicine for improving sleep and nourishing bowel and relieving constipation and its preparation |
| 05/27/2009 | CN100490842C Headache treating medicine |
| 05/27/2009 | CN100490837C Use of Dafabiao extract in pharmacy |
| 05/27/2009 | CN100490825C Aqueous extracts of analgesic from woodfrog and its preparation |
| 05/27/2009 | CN100490813C Application of thiophosphorylation amino and its methyl in preparation of drug for relieving chronic pain |
| 05/27/2009 | CN100490810C Flashmelt oral dosage formulation |
| 05/27/2009 | CN100490801C Ginkgolide B dropping pill and its preparing method |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538138 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders |
| 05/26/2009 | US7538121 Vanilloid receptor modulators |
| 05/26/2009 | US7538118 6-aminomorphinane derivatives, method for production and use thereof |
| 05/26/2009 | US7538109 Quinoxalin-3-one derivatives as orexin receptor antagonists |
| 05/26/2009 | US7538106 Application of 2-cyano-10- (2-methyl-3- (methylamino)- propyl) phenothiazine or a pharmaceutically acceptable salt as medicament |